These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8287379)

  • 1. Biological activity of a K-ras mutant that contains the 12R/59T/116Y mutations.
    Ogiso Y; Hwang YW; Shih TY; Kuzumaki N
    Cancer Lett; 1993 Nov; 75(1):19-26. PubMed ID: 8287379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
    Kaplan JB
    Oncol Res; 1994; 6(12):611-5. PubMed ID: 7787254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of NIH3T3 cells to v-fes transformation induced by a dominant negative H-ras mutant.
    Ogiso Y; Yokoyama T; Watari H; Shih TY; Kuzumaki N
    Exp Cell Res; 1993 Oct; 208(2):415-21. PubMed ID: 7690710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme.
    Funato T; Shitara T; Tone T; Jiao L; Kashani-Sabet M; Scanlon KJ
    Biochem Pharmacol; 1994 Oct; 48(7):1471-5. PubMed ID: 7945447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells.
    Sakai N; Ogiso Y; Fujita H; Watari H; Koike T; Kuzumaki N
    Exp Cell Res; 1994 Nov; 215(1):131-6. PubMed ID: 7957661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells.
    Kyprianou N; Taylor-Papadimitriou J
    Oncogene; 1992 Jan; 7(1):57-63. PubMed ID: 1741165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
    Saez R; Chan AM; Miki T; Aaronson SA
    Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells.
    Cox LR; Motz J; Troll W; Garte SJ
    Cancer Res; 1991 Sep; 51(18):4810-4. PubMed ID: 1893373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes.
    Spandidos DA; Frame M; Wilkie NM
    Anticancer Res; 1990; 10(6):1543-54. PubMed ID: 2285227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled overexpression of selected domains of the P85 subunit of phosphatidylinositol 3-kinase reverts v-Ha-Ras transformation.
    Zhang QX; Davis ID; Baldwin GS
    Biochim Biophys Acta; 1996 Jul; 1312(3):207-14. PubMed ID: 8703989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts.
    Wani MA; Denko NC; Stambrook PJ
    Somat Cell Mol Genet; 1997 Mar; 23(2):123-33. PubMed ID: 9330640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.